Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis.

Sindhu Chadalawada Anis Rassi Omar Samara Anthony Monzon Deepika Gudapati Lilian Vargas Barahona Peter HysonStefan SillauLuisa Mestroni Matthew R G Taylor Maria da Consolação Vieira Moreira Kristen Desanto Nelson Iván Agudelo Higuita Carlos Franco-Paredes Andrés F Henao Martinez

Published in: ESC heart failure (2021)

The annual mortality risk in chronic Chagas cardiomyopathy is substantial and primarily attributable to cardiovascular causes. This risk significantly increases in patients with low left ventricular ejection fraction and those classified as AHA stages C and C/D.

Keyphrases

ejection fraction
aortic stenosis
heart failure
left ventricular
trypanosoma cruzi
transcatheter aortic valve replacement
acute myocardial infarction
mitral valve
hypertrophic cardiomyopathy
cardiac resynchronization therapy
acute coronary syndrome
drug induced